Search

everythinglearnresearchcommunity

for

Search:↓

A rare scalp condition causing hair loss and cysts in young men can be treated effectively with a specific steroid injection.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

No cure exists for alopecia areata, and treatments are personalized.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Hair loss linked to higher heart disease risk in both men and women.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Iron deficiency is not a significant cause of hair loss in women.

Congenital Triangular Alopecia is a rare, non-scarring hair loss that can be surgically treated in females for cosmetic reasons.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.